Dr. Salz’ research aims to improve the quality of care for cancer survivors, focusing primarily on late effects after cancer treatment. Her research addresses survivorship interventions, including needs assessments, clinical intervention development, and effectiveness testing. She currently leads an NCI grant to develop an automated survivorship care plan for head and neck cancer survivors that is responsive to their needs while creating minimal burden for the oncology team. Another area of research she pursues addresses risk stratification of survivorship care through late effects modeling. With funding from the Leukemia and Lymphoma Society and the NCI, she is developing models to predict the risk of cardiovascular late effects among lymphoma survivors to guide cardiovascular preventive care for this vulnerable population. She also is investigating trends in pain management among cancer survivors.